select trial semaglutide results NEJM on X: "In patients w/ cardiovascular disease & overweight or obesity but no diabetes, was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean The SELECT Trial - A

Request a Consultation Semaglutide, known by the brand name Ozempic, is a medication that mimics the effects of a hormone called GLP-1, which helps regulate appetite and insulin production

This means the body burns fewer calories at rest

Lets look at each of these in more detail: Anxiety disorders, PTSD: As an inhibitory neurotransmitter, GABA puts the brakes on the release of neuropeptides in the brain that activate the hypothalamic-pituitary-adrenal (HPA) axis

An imbalance in the gut microbial community can trigger inflammatory responses and modulate GLP-1 secretion, while GLP-1 itself may influence both immune signaling and microbial composition

The nausea that many users experience during the early weeks further suppresses fluid intake

Scores on the Alcohol Craving Questionnaire-Short Form also improved (p=0.027), although laboratory-based visual analogue craving scores remained unchanged